Roflumilast (daliresp): a novel phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease.
Article Details
- CitationCopy to clipboard
Baye J
Roflumilast (daliresp): a novel phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease.
P T. 2012 Mar;37(3):149-61.
- PubMed ID
- 22605906 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs
- Drug Enzymes
Drug Enzyme Kind Organism Pharmacological Action Actions Roflumilast Cytochrome P450 3A4 Protein Humans NoSubstrateDetails